The A. municiphila-mediated reprogramming of monocytes was shown to significantly enhance tumor mass reduction of anti-PD-L1 therapy, suggesting a synergistic link between STING-dependent IFN-I activation and checkpoint blockade [116]. This evidence concerns the gene STING1 and neoplasm.